MK2206, a selective AKT inhibitor, modulates ovarian cancer cell line sensitivity to carboplatin plus paclitaxel

✍ Scribed by N. Bou Zgheib; D. Marchion; Y. Xiong; X. Stickles; P. Judson; A. Hakam; J. Gonzalez Bosquet; R. Wenham; S. Apte; J. Lancaster

• Book ID: 113963898
• Publisher: Elsevier Science
• Year: 2012
• Tongue: English
• Weight: 65 KB
• Volume: 125
• Category: Article
• ISSN: 0090-8258
• DOI: 10.1016/j.ygyno.2011.12.343